Results 121 to 130 of about 16,872 (258)
Respondent Behavior in Panel Studies: A Case Study for Income-Nonresponse by Means of the German Socio-Economic Panel (GSOEP) [PDF]
Many validation studies deal with item-nonresponse and measurement error in earnings data. In this paper we explore motives of respondents for the failure to reveal earnings using the German Socio-Economic Panel (GSOEP).
Jörg-Peter Schräpler
core
Item Non-response and Imputation of Annual Labor Income in Panel Surveys from a Cross-National Perspective [PDF]
Using data on annual individual labor income from three representative panel datasets (German SOEP, British BHPS, Australian HILDA) we investigate a) the selectivity of item non-response (INR) and b) the impact of imputation as a prominent post-survey ...
Markus M. Grabka, Joachim R. Frick
core +2 more sources
Molecular Oncology, EarlyView.This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Measurement error in long-term retrospective recall surveys of earnings
, 2007 Several recent studies in labour and population economics use retrospective surveys to substitute for the high cost and limited availability of longitudinal survey data.
Gibson, John, Kim, Bonggeun
core
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Molecular Oncology, EarlyView.Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens +6 more
wiley +1 more source
Molecular Oncology, EarlyView.We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober +16 more
wiley +1 more source
Feeding back Information on Ineligibility from Sample Surveys to the Frame
, 2003 It is usually discovered in the data collection phase of a survey that some units in the sample are ineligible even if the frame information has indicated otherwise.
Hedlin, Dan, Wang, Suojin
core
State-based Diabetes Surveillance Among Minority Populations
Preventing Chronic Disease, 2004 The elimination of health disparities in the United States is a national priority and overriding goal for Healthy People 2010 (HP 2010). Surveillance of health indicators among minority populations is essential to eliminating disparities. Surveillance is
Jay Desai
doaj
Molecular Oncology, EarlyView.Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi +14 more
wiley +1 more source